F. Carmona

发表

Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment.

R. Casamitjana, J. Balasch, F. Fábregues, 1996, American journal of obstetrics and gynecology.

Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus

G. Espinosa, F. Muñoz-Rodríguez, J. Balasch, 2002, Lupus.

Infertility factors and pregnancy outcome in women above age 35.

J. Balasch, F. Fábregues, J. Vanrell, 1992, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases.

R. Cervera, J. Balasch, J. Font, 1999, European journal of obstetrics, gynecology, and reproductive biology.

Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.

G. Espinosa, F. Muñoz-Rodríguez, J. Font, 1999, Seminars in arthritis and rheumatism.

Antiphospholipid antibodies and human reproductive failure.

J. Balasch, J. Font, D. Tàssies, 1996, Human reproduction.

Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)

J. Balasch, J. Font, J. Reverter, 1999, Human reproduction.

Haemodynamic and respiratory mechanics in cardiogenic pulmonary oedema patients: a clinical bedside study

A. J. Chaumel, J. Miranda, A. G. Cano, 1997 .

Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

G. Espinosa, F. Muñoz-Rodríguez, J. Font, 2000, Haematologica.

Transferrin Receptor (CD71) Expression in Peritoneal Macrophages from Fertile and Infertile Women With and Without Endometriosis

R. Vilella, J. Balasch, F. Carmona, 1997, American journal of reproductive immunology.

Total circulating microparticle levels are increased in patients with deep infiltrating endometriosis

J. Balasch, J. Munrós, J. Reverter, 2017, Human reproduction.

Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation

J. Llach, W. Jiménez, V. Arroyo, 1991, Fertility and sterility.

Ovulation side and ovarian cancer.

J. Balasch, S. Mirkin, J. Vanrell, 1994, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome.

J. Llach, V. Arroyo, J. Balasch, 1990, Human reproduction.

Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.

J. Balasch, F. Fábregues, M. Creus, 1996, Human reproduction.

Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.

R. Casamitjana, J. Balasch, F. Fábregues, 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome.

J. Balasch, J. Font, M. Ingelmo, 1993, Human reproduction.

Biomechanical characteristics of the ovarian cortex in POI patients and functional outcomes after drug-free IVA

J. Otero, J. M. Calafell, F. Carmona, 2022, Journal of Assisted Reproduction and Genetics.

Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program.

J. Balasch, F. Fábregues, S. Cívico, 1998, Fertility and sterility.

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.

R. Casamitjana, J. Balasch, F. Fábregues, 2001, Human reproduction.

Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot.

R. Casamitjana, J. Balasch, F. Gomez, 1992, Human reproduction.

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.

R. Casamitjana, J. Balasch, F. Carmona, 2000, Human reproduction.